Related Experiment Videos
Lepromatous vasculitis successfully treated by plasma exchange (PE)
M R Ruzzenenti1, R Bruni, G Florio
1Immunohematology Service, S. Martino University Hospital, Genova, Italy.
Journal of Clinical Apheresis
|April 20, 2001
Summary
Circulating immune complexes (CIC) drive vascular disease in leprosy. Plasma exchange (PE) effectively treated lepromatous vasculitis in a patient, demonstrating PE
Area of Science:
- Immunology
- Pathology
- Rheumatology
Background:
- Vascular involvement is a common pathway in diseases mediated by circulating immune complexes (CIC).
- Lepromatous leprosy involves CIC, leading to vascular lesions and an Arthus-like mechanism.
- Lucio's phenomenon shares this mechanism, causing vascular infiltrates and skin infarction.
Observation:
- Lepromatous vascular disease is mediated by CIC with known antigen composition.
- Similar mechanisms are implicated in HCV-related cryoglobulinemia, HBV-associated panarteritis nodosa, rheumatoid vasculitis, and granulomatosis with polyangiitis.
- Plasma exchange (PE) has been used for lepromatous vasculitis since 1979.
Findings:
- This report details another successful treatment of lepromatous vasculitis using plasma exchange.
- The patient's condition improved following plasma exchange therapy.
Implications:
- Plasma exchange is a viable therapeutic option for lepromatous vasculitis.
- Understanding CIC-mediated pathways is crucial for managing various immune-driven vascular diseases.
- Further research into PE's efficacy in similar conditions is warranted.